Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Visningar
• 06/15/23
0
0
Bädda in
administrator
Prenumeranter
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna